These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 2413296

  • 1. Electrophysiology of the enantiomers of disopyramide in dogs.
    Giacomini JC, Giacomini KM, Nelson WL, Harrison DC, Blaschke TF.
    J Cardiovasc Pharmacol; 1985; 7(5):884-90. PubMed ID: 2413296
    [Abstract] [Full Text] [Related]

  • 2. Dehydrobenzperidol and disopyramide in A-V conduction.
    Pérez-Medina T, Taín J, Rérez A, García-Barreto D.
    Eur J Pharmacol; 1976 Jul; 38(1):215-7. PubMed ID: 954832
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of combined administration of verapamil and disopyramide in dogs.
    Lee JT, Davy JM, Kates RE.
    J Cardiovasc Pharmacol; 1985 Jul; 7(3):501-7. PubMed ID: 2410681
    [Abstract] [Full Text] [Related]

  • 4. Hemodynamic and electrophysiologic effects of disopyramide enantiomers in a canine blood superfusion model.
    Kidwell GA, Lima JJ, Schaal SF, Muir WW.
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):644-55. PubMed ID: 2471004
    [Abstract] [Full Text] [Related]

  • 5. Electrophysiological effects of disopyramide in patients with bundle branch block.
    Desai JM, Scheinman M, Peters RW, O'Young J.
    Circulation; 1979 Feb; 59(2):215-25. PubMed ID: 758989
    [Abstract] [Full Text] [Related]

  • 6. The direct electrophysiologic effects of disopyramide phosphate in the transplanted human heart.
    Bexton RS, Hellestrand KJ, Cory-Pearce R, Spurrell RA, English TA, Camm AJ.
    Circulation; 1983 Jan; 67(1):38-45. PubMed ID: 6401173
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparative class 1 electrophysiologic and anticholinergic effects of disopyramide and its main metabolite (mono-N-dealkylated disopyramide) in healthy humans.
    Bergfeldt L, Schenck-Gustafsson K, Dahlqvist R.
    Cardiovasc Drugs Ther; 1992 Oct; 6(5):529-37. PubMed ID: 1450096
    [Abstract] [Full Text] [Related]

  • 9. [Effects of disopyramide on normal and pathological atrioventricular conduction].
    Barnay C.
    Ann Cardiol Angeiol (Paris); 1992 Oct; 41(8):449-53. PubMed ID: 1298185
    [Abstract] [Full Text] [Related]

  • 10. Electrophysiologic effects of the antiarrhythmic agent disopyramide phosphate.
    Befeler B, Castellanos A, Wells DE, Vagueiro MC, Yeh BK.
    Am J Cardiol; 1975 Feb; 35(2):282-7. PubMed ID: 1119389
    [Abstract] [Full Text] [Related]

  • 11. Antiarrhythmic, electrophysiologic and hemodynamic effects of ACC-9358.
    Brown BS, Calzadilla SV, Diemer MJ, Hartman JC, Reynolds RD.
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1225-34. PubMed ID: 3694532
    [Abstract] [Full Text] [Related]

  • 12. Electrophysiologic effects of disopyramide phosphate on reentrant ventricular arrhythmia in conscious dogs after myocardial infarction.
    Patterson E, Gibson JK, Lucchesi BR.
    Am J Cardiol; 1980 Nov; 46(5):792-9. PubMed ID: 7435389
    [Abstract] [Full Text] [Related]

  • 13. The electrophysiology of Norpace (Part I).
    Dreifus LS.
    Angiology; 1975 Jan; 26(1 Pt 2):111-5. PubMed ID: 1115397
    [No Abstract] [Full Text] [Related]

  • 14. Electrophysiologic effects of bepridil in the anesthetized dog studied by endocardiac electrodes.
    Sassine A, Masse C, Fajuri A, Hirsch JL, Labrid C, Puech P.
    Am J Cardiol; 1984 Jun 01; 53(11):1707-11. PubMed ID: 6610347
    [Abstract] [Full Text] [Related]

  • 15. Electrophysiology of disopyramide in man.
    Ross D, Vohra J, Cole P, Hunt D, Sloman G.
    Aust N Z J Med; 1978 Aug 01; 8(4):377-83. PubMed ID: 282851
    [Abstract] [Full Text] [Related]

  • 16. Cardiac electrophysiologic effects of quinidine and propranolol isomers in anesthetized dogs: concentration-response relationships.
    Jaillon P, Heckle J, Aubry JP, Weissenburger J, Cheymol G.
    J Cardiovasc Pharmacol; 1981 Aug 01; 3(3):431-45. PubMed ID: 6168825
    [Abstract] [Full Text] [Related]

  • 17. Electrophysiologic effects of sodium channel blockade on anisotropic conduction and conduction block in canine myocardium: preferential slowing of longitudinal conduction by flecainide versus disopyramide or lidocaine.
    Kondo T, Yamaki M, Kubota I, Tachibana H, Tomoike H.
    J Am Coll Cardiol; 1997 Jun 01; 29(7):1639-44. PubMed ID: 9180130
    [Abstract] [Full Text] [Related]

  • 18. Combined effect of disopyramide and bethanechol: use of bethanechol to prevent anticholinergic side effects of disopyramide without reduction of antiarrhythmic efficacy.
    Konishi T, Kadoya M, Ikeguchi S, Sakai K, Tamamura T, Kawai C.
    J Cardiovasc Pharmacol; 1989 Aug 01; 14(2):341-50. PubMed ID: 2476611
    [Abstract] [Full Text] [Related]

  • 19. In vivo canine cardiac electrophysiologic profile of 1,4-benzodiazepine IKs blockers.
    Stump GL, Smith GR, Tebben AJ, Jahansouz H, Salata JJ, Selnick HG, Claremon DA, Lynch JJ.
    J Cardiovasc Pharmacol; 2003 Jul 01; 42(1):105-12. PubMed ID: 12827034
    [Abstract] [Full Text] [Related]

  • 20. Stereoselective effects of disopyramide enantiomers in humans.
    Lima JJ, Boudoulas H.
    J Cardiovasc Pharmacol; 1987 May 01; 9(5):594-600. PubMed ID: 2439842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.